This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT06040099
Brief Title: A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE (EMERALD-Y90)
First Submitted : September 11, 2023
First Submitted that Met QC Criteria : September 11, 2023
First Posted : September 15, 2023
Last Update Submitted that Met QC Criteria : September 11, 2023
Last Update Posted : September 15, 2023